Johnson & Johnson (ETR:JNJ)
175.94
-2.34 (-1.31%)
Dec 22, 2025, 5:35 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€570,643
Profits / Employee
€155,552
Market Cap
424.82B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Johnson & Johnson News
- 15 hours ago - Rep. Thomas Kean Has Sold Up to $100K Worth Of Johnson & Johnson Stock: Here's What You Should Know - Benzinga
- 1 day ago - Johnson & Johnson hit with another giant asbestos-talcum powder verdict: $65.5 million in Minnesota - Fortune
- 2 days ago - Why a Minnesota Jury Ordered Johnson & Johnson To Pay $65.5 Million in Damages - Benzinga
- 2 days ago - Jury says Johnson & Johnson owes woman $65.5 million - NBC News
- 2 days ago - Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder - New York Post
- 3 days ago - Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson - Business Wire
- 3 days ago - JNJ Today: Goldman Sachs Raises Johnson & Johnson Price Target | JNJ Stock News - GuruFocus
- 3 days ago - Johnson & Johnson (JNJ) Gains FDA Approval for New Lung Cancer Treatment - GuruFocus